Defining post-obstructive diuresis following posterior urethral valve ablation

定义后尿道瓣膜消融术后梗阻性利尿

阅读:1

Abstract

INTRODUCTION: Posterior urethral valves (PUV) are the most common cause of congenital lower urinary tract obstruction. Patients are at risk for post-obstructive diuresis (POD) following management of this obstruction which may prolong and/or complicate their subsequent hospital course. Despite this known physiologic effect, there is minimal data to define which patients are at highest risk for POD. Our objective was to define an initial urine output threshold for neonatal post-obstructive diuresis. METHODS: A retrospective chart review was conducted on patients that were admitted to our Newborn and Infant Critical Care Unit (NICCU), in a tertiary care children's hospital, between 2004 and 2019 and underwent cystoscopic valve ablation for PUV. Outcomes of interest were length of hospital stay after posterior urethral valve ablation, serum creatinine and electrolyte values, fluid intake, and urine output at 4- and 24-h post-valve ablation. Chi-squared, Fisher's exact, and T-tests were conducted for descriptive statistical analyses as appropriate. Logistic regression analyses were conducted with adjusted models including patient demographic and clinical data. RESULTS: Forty patients met inclusion criteria and the mean age at time of valve ablation was 11.2 days. Pre-operatively, maximum creatinine levels (ng/dl) achieved had a median value of 0.7 (IQR: 0.5-1.5). Post-operatively, the mean urine output (mL/kg/h) at 4-h was 4.2 ± 3.7, and at 24-h was 4.5 ± 2.2. Logistic regression analyses showed that those with a post-operative 24-h UOP > 3.5 ml/kg/h had more than 5 times the odds of a prolonged hospital length of stay (LOS) > 3 days (OR: 5.50; 95% CI: 1.23-24.51). DISCUSSION: Neonates with PUV who undergo valve ablation are at risk of POD. Our findings suggest greater urine output after ablation to be a predictor of increased hospital length of stay. Utilizing a urine output (UOP) of >3.5 mL/kg/h may serve as a starting point for defining POD after posterior urethral valve ablation.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。